Steroid-free immunosuppression in organ transplantation

Current Diabetes Reports

Volumn 5, Issue 4, 2005, Pages 305-310

  Luo, Gaoxing ^b   Falta, Edward M ^b   Elster, Eric A ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ANEMIA; AVASCULAR NECROSIS; CATARACT; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; FRACTURE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER TRANSPLANTATION; LYMPHOMA; MAINTENANCE THERAPY; META ANALYSIS; MYOPATHY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; OSTEOPENIA; OSTEOPOROSIS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PSYCHOSIS; REVIEW; SKIN CANCER; SYSTEMATIC REVIEW; THROMBOSIS; WOUND HEALING IMPAIRMENT;

EID: 24644443392     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0028-x     Document Type: Review

References (51)

1. Billingham RE, Krohn PL, Medawar PB: Effect of cortisone on survival of skin homografts in rabbits. BMJ 1951, 1:1157-1163.
2. Starzl TE, Marchioro TL, Waddel WR: The reversal of rejection in human renal homograft with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963, 17:385-395.
3. Auphan N, DiDonato JA, Rosette C, et al.: Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of IkB synthesis. Science 1995, 270:286-290.
4. Kirk AD, Elster EA: Transplant immunology. In Surgery: Basic Science and Clinical Evidence. Edited by Norton JA et al. New York: Springer-Verlag; 2004:1403-1430.
5. Offermann G: Immunosuppression for long-term maintenance of renal allograft function. Drug 2004, 64:1325-1338.
6. Trofe J, Beebe TM, Buell JF, et al.: Posttransplant malignancy. Prog Transplant 2004, 14:193-200.
7. Birkeland SA, Andersen HK, Hamilton DSJ: Preventing acute rejection, Epstein-Barr Virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of acyclovir and mycophenolate mofetil in a steroid-free immuno-suppressive protocol. Transplantation 1999, 67:1209-1214.
8. Babel N, Schwarzmann F, Prang N, et al.: Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients. Transplantation 2001, 72:736-739.
9. Koshiba T, Kitade H, Waer M, et al.: Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation. Transplant Proc 2003, 35:3153-3155.
10. Wang C, Sun J, Sheil AGR, et al.: A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001, 72:44-51.
11. Hricik DE, Schulak JA: Metabolic effects of steroid withdrawal in adult renal transplant recipients. Kidney Int 1993, 43:S26-S30.
12. Grotz WH, Rump LC, Niessen A, et al.: Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 1998, 66:1004-1008.
13. Sartori TM, Maurizio PG, Sara P, et al.: Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. J Heart Lung Transplant 1999, 18:693-700.
14. Fryer JP, Granger DK, Leventhal JR, et al.: Steroid-related complications in the cyclosporine era. Clin Transplant 1994, 8(3 Pt 1):224-229.
15. Leonard MB, Bachrach LK: Assessment of bone mineralization following renal transplantation in children: limitation of DXA and the confounding effects of delayed growth and development. Am J Transplant 2001, 1:193-199.
16. Shapiro PA, Kornfeld DS: Psychiatric outcome of heart transplantation. Gen Hosp Psychiatry 1989, 11:352-357.
17. Ingram DG, Hagemann TM: Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother 2003, 37:1036-1039.
18. Veenstra DL, Best JH, Hornberger J, et al.: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999, 33:829-835.
19. Cyclosporin as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial [no authors listed]. Lancet 1982, 2:57-60.
20. Kasiske BL, Chakkera HA, Louis TA, Ma JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000, 11:1910-1917.
21. Lerut JP: Avoiding steroids in solid organ transplantation. Transpl Int 2003, 16:213-224.
22. Nashan B, Moore B, Amlot P, et al.: Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997, 350:1193-1198.
23. Kino T, Hatanaka H, Miyata S, et al.: FK-506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 1987, 40:1256-1265.
24. Plaz KP, Sollinger HW, Hullet DA, et al.: RS-61443, a new, otent immunosuppressive agent. Transplantation 1991, 51:27-31.
25. Mital D, Podlasek W, Jensik SC: Sirolimus-based steroid-free maintenance immunosuppression. Transplantation Proc 2002, 34:1709-1710.
26. Kung SC, Fyfe PB, Xiao SG, et al.: Simulect induction facilitates neural-based steroid-free immunosuppression in primary kidney transplant recipients. Transplantation Proc 2004, 36:475s-477s.
27. Cole E, Landsberg D, Russell D, et al.: A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001, 72:845-850.
28. Calne R, Friend P, Moffatt S, et al.: Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998, 351:1701-1702.
29. Calne R, Moffatt SD, Friend PJ, et al.: Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999, 68:1613-1616.
30. Swanson SJ, Hale DA, Mannon RB, et al.: Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002, 360:1662-1664.
31. Knechtle SJ, Pirsch JD, Fechner J, et al.: Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003, 3:722-730.
32. Sarwal M, Vidhun JR, Alexander SR, et al.: Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003, 76:1331-1339.
33. Hricik D, Knauss T, Bodziak K, et al.: Long-term renal allograft survival and function after steroid withdrawal in African Americans receiving sirolimus and tacrolimus. Am J Transplant 2004, 4(suppl 8):298.
34. Boardman RE, Alloway RR, Alexander JW, et al.: African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant 2005, 5:356-365.
35. Ringe B, Braun F, Schutz, et al.: A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation 2001, 71:508-515.
36. Reding R, Gras J, Sokal E, et al.: Steroid free liver transplantation in children. Lancet 2003, 362:268-270.
37. Eason JD, Loss GE, Blazek J, et al.: Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl 2001, 7:693-697.
38. Eason JD, Cohen AJ, Nair S, et al.: Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation 2003, 75:1396-1399.
39. Kato T, Yoshida H, Martinez E, et al.: Steroid-free induction and pre-emptive antiviral therapy for liver transplant recipients with hepatitis C- a preliminary report from a prospective randomized study [abstract #2-18]. Paper presented at the ASTS 5th Annual State of the Art Winter Symposium. Miami, FL; January 21-23, 2005.
40. Ryan EA: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148-2157.
41. Brendel M, Hering B, Schulz A, Bretzel R: International Islet Transplant Registry Report. Giessen, Germany: University of Giessen; 1999.
42. Shapiro AMJ, Lakey JRT, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
43. Cantarovich D, Giral-Classe M, Hourmant M, et al.: Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive studies. Transplantation 2000, 69:1505-1509.
44. Kaufman DB, Leventhal JR, Koffron AJ, et al.: A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002, 73:169-177.
45. Vincenti F, Stock P: De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplant Proc 2003, 35 (suppl 3A):183s.
46. Freise CE, Kang SM, Feng S, et al.: Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc 2004, 36:1067-1068.
47. Yacoub M, Alivizator P, Khaghani A, Mitchell A: The use of cyclosporine, azathioprine, and antithymocyte globulin with or without low-dose steroids for immunosuppression of cardiac transplant patients. Transplant Proc 1985, 17:221-222.
48. Hosenpud JD, Bennett LE, Keck BM, et al.: The registry of international society for heart and lung transplantation: fifteenth official report - 1998. J Heart Lung Transplant 1998, 17:656-659.
49. Pritzker MR, Lake KD, Reutzel TJ, et al.: Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience. J Heart Lung Transplant 1992, 11(2 Pt 2):415-420.
50. Livi U, Gambino CA, Stellin MG, et al.: Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results. Transplant Proc 1998, 30:1975-1976.
51. Leonard H, Hornung T, Parry G, Dark JH: Pediatric cardiac transplant: results using a steroid-free maintenance regimen. Pediatr Transplant 2003, 7:59-63.